Yes, the so called "bad actors" seem to have left, but also left the share price and the overall market sentiment of the GNBT stock devastated, which - in my view - also is the reason why the share price didn't really move on the great news from yesterday, or the other things you mentioned in your list.
Plus, of course, the very much delayed exit off the laboratory testing phase, and (hopefully) soon to be starting clinical trial phase.
I guess GNBT really needs to put more effort into telling THE WORLD about the reasons why this "Complete Vaccine" is still very much needed.
In my view, the way yesterday's PR was written was a little step into the right direction, as I found it more informative as the once in recent history, but still there is A LOT OF ROOM for further improvements.
Especially when it comes to explaining how and when these positive lab results can be turned into generated revenues and profits. In my view, THAT is - prior to actually generating these streams of income - what they should really emphasis there PRs on. So far they are too much into providing the academic information that they seem to be very excited about, but they have to face the fact that they are now showing up very late to the race of vaccine development, and they should make a better job to explain why it is still not too late, and it will still be able to make A LOT OF money with this vaccine. I guess most people do not really see that with millions of vaccine doses already being administed daily all over the globe.
One lead in this regard would be lying more emphasis also on the therapeutic aspect they mentioned yesterday, which I am honestly not too sure what this is all about exactly. And when I, as a very well informed long time GNBT investor, am not sure about this, there is a hell of a lot ground to be broken, in order to let THE WORLD know what they've got there.
Plus, of course, the very much delayed exit off the laboratory testing phase, and (hopefully) soon to be starting clinical trial phase.
I guess GNBT really needs to put more effort into telling THE WORLD about the reasons why this "Complete Vaccine" is still very much needed.
In my view, the way yesterday's PR was written was a little step into the right direction, as I found it more informative as the once in recent history, but still there is A LOT OF ROOM for further improvements.
Especially when it comes to explaining how and when these positive lab results can be turned into generated revenues and profits. In my view, THAT is - prior to actually generating these streams of income - what they should really emphasis there PRs on. So far they are too much into providing the academic information that they seem to be very excited about, but they have to face the fact that they are now showing up very late to the race of vaccine development, and they should make a better job to explain why it is still not too late, and it will still be able to make A LOT OF money with this vaccine. I guess most people do not really see that with millions of vaccine doses already being administed daily all over the globe.
One lead in this regard would be lying more emphasis also on the therapeutic aspect they mentioned yesterday, which I am honestly not too sure what this is all about exactly. And when I, as a very well informed long time GNBT investor, am not sure about this, there is a hell of a lot ground to be broken, in order to let THE WORLD know what they've got there.
3
